Archive — US — techcrunch
Linda Yaccarino joins health tech platform eMed as CEO after leaving X
Linda Yaccarino has been appointed CEO of health tech startup eMed Population Health after leaving X. Yaccarino, known for her successful ad strategies at NBCUniversal and X, will lead eMed in developing a tech platform focusing on GLP-1 drugs to improve healthcare outcomes, despite lacking prior health tech experience.
Key points
- Linda Yaccarino joins eMed Population Health as CEO after leaving X.
- eMed is an AI startup focused on developing a tech platform for GLP-1 drugs.
- Yaccarino's expertise in negotiating partnerships and her reputation in the tech industry were critical in her appointment.
- eMed previously worked on a platform for at-home COVID-19 testing.
- Yaccarino aims to redefine healthcare with innovative services to improve health outcomes.
Why it matters
- The rise of health tech companies represents a growing trend in the industry towards integrating AI in healthcare by 2025.
- Yaccarino's transition from media to health tech mirrors similar shifts in leadership across sectors as technology interlinks various industries.
- The focus on GLP-1 medications reflects current healthcare priorities in managing obesity and diabetes, aligning with broader health conversations.
Yaccarino's appointment at eMed marks a significant step in her career and highlights the increasing importance of tech integration in healthcare, aligning with prominent trends for 2025.